Login Register
English
0

Cart

$ 0

LITAF Polyclonal Antibody

LITAF Polyclonal Antibody

Views(4) Publications(0) Catalog no(ABP59126)
Datasheet Print Share Email Share
  • Specification
  • FAQ
  • Publications(0)
  • Comments(0)

Specification

Product name LITAF Polyclonal Antibody
Immunogen Synthesized peptide derived from part region of human LITAF protein
Host Rabbit
Reactivity Human,Rat,Mouse
Applications WB,ELISA
Applications notes Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000;ELISA 1:5000-20000
Clonality Polyclonal
Preparation method The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Alternative Small integral membrane protein of lysosome/late endosome; p53-induced gene 7 protein

Product Properties

Formulation Liquid solution
Concentration 1 mg/ml
Molecular weight 17kD
Storage buffer PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
Storage instructions Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Shipping Gel pack with blue ice.
Precautions The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Additional Information

Background Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. LITAF encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of LITAF is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in LITAF cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for LITAF.
Gene ID 9516
Alternative Small integral membrane protein of lysosome/late endosome; p53-induced gene 7 protein
Others The antibody detects endogenous levels of LITAF protein
Accession Q99732
Observed Band(KD) 17

Image & description

This product has been cited in0publications

Reviews

There are no reviews yet.

Be the first to review “LITAF Polyclonal Antibody”